Keeps Biopharma Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 99

Employees

  • Stock Symbol
  • 256940

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $3.66
  • (As of Friday Closing)

Keeps Biopharma General Information

Description

Keeps Biopharma Inc Formerly KPS Corp manufactures cleanroom consumables. Its products include wiper, poly tape, sticky roll and adhesive roll.

Contact Information

Formerly Known As
KPS (Electronic Equipment and Instruments), KPS Company
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 52 Dongtansandan 10-gil
  • Hwaseong-si, Gyeoggi-do 18487
  • South Korea
Primary Industry
Electronic Equipment and Instruments
Other Industries
Biotechnology
Other Hardware
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 52 Dongtansandan 10-gil
  • Hwaseong-si, Gyeoggi-do 18487
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Keeps Biopharma Stock Performance

As of 13-Nov-2026, Keeps Biopharma’s stock price is $3.66. Its current market cap is $73.5M with 20.1M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.66 $3.59 $3.15 - $8.89 $73.5M 20.1M 42.7K -$0.43

Keeps Biopharma Financials Summary

As of 30-Jun-2026, Keeps Biopharma has a trailing 12-month revenue of $152M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 130,507 177,218 82,964 123,779
Revenue 151,922 119,558 93,506 70,468
EBITDA (5,710) (879) 6,559 5,991
Net Income (8,537) (6,876) 816 3,006
Total Assets 151,577 162,441 113,369 91,007
Total Debt 61,737 64,300 37,840 37,484
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Keeps Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Keeps Biopharma‘s full profile, request access.

Request a free trial

Keeps Biopharma Patents

Keeps Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024027747-A Device, method, program, and system Active 18-Aug-2022
JP-2023033115-A Method for manufacturing vapor deposition mask frame assembly for display panel Active 25-Aug-2021
US-12422742-B2 Method of manufacturing deposition mask frame assembly for display panel Active 25-Aug-2021
US-20230062020-A1 Method of manufacturing deposition mask frame assembly for display panel Active 25-Aug-2021
US-12509758-B2 Hybrid stick mask and manufacturing method therefor, mask assembly including hybrid stick mask, and organic light emitting display device using same Active 24-May-2019 C23C14/042
To view Keeps Biopharma’s complete patent history, request access »

Keeps Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Keeps Biopharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Keeps Biopharma‘s full profile, request access.

Request a free trial

Keeps Biopharma Investments & Acquisitions (7)

Keeps Biopharma’s most recent deal was a Merger/Acquisition with Elpis Biopharmaceuticals. The deal was made on 03-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Elpis Biopharmaceuticals 03-Mar-2026 Merger/Acquisition Drug Discovery
AMPLY Discovery 08-Jan-2026 Later Stage VC Discovery Tools (Healthcare)
Korea Global Pharmaceutical 21-Feb-2025 Secondary Transaction - Private Pharmaceuticals
KB Biomed 14-Feb-2025 Merger/Acquisition Drug Discovery
Korea Global Pharmaceutical 24-Jan-2025 Merger/Acquisition Pharmaceuticals
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Keeps Biopharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Semiconductors

Industry

Rank

Percentile

Semiconductor Equipment

Subindustry

Rank

Percentile

To view Keeps Biopharma’s complete esg history, request access »

Keeps Biopharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Segi Retech Yeongcheon, South Korea 2010

Keeps Biopharma FAQs

  • When was Keeps Biopharma founded?

    Keeps Biopharma was founded in 2000.

  • Where is Keeps Biopharma headquartered?

    Keeps Biopharma is headquartered in Hwaseong-si, South Korea.

  • What is the size of Keeps Biopharma?

    Keeps Biopharma has 99 total employees.

  • What industry is Keeps Biopharma in?

    Keeps Biopharma’s primary industry is Electronic Equipment and Instruments.

  • Is Keeps Biopharma a private or public company?

    Keeps Biopharma is a Public company.

  • What is Keeps Biopharma’s stock symbol?

    The ticker symbol for Keeps Biopharma is 256940.

  • What is the current stock price of Keeps Biopharma?

    As of 13-Nov-2026 the stock price of Keeps Biopharma is $3.66.

  • What is the current market cap of Keeps Biopharma?

    The current market capitalization of Keeps Biopharma is $73.5M.

  • What is Keeps Biopharma’s current revenue?

    The trailing twelve month revenue for Keeps Biopharma is $152M.

  • What is Keeps Biopharma’s annual earnings per share (EPS)?

    Keeps Biopharma’s EPS for 12 months was -$0.43.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process